Board Vitals Questions Flashcards
What meds are FDA approved to treat bipolar depression?
Seroquel
Latuda
Zyprexa + Prozac
What are Standard Deviations?
68-95-99.7
Sleep Stages
Stage 1 - 5%
State 2 - 50% (sleep spindles and K-complexes on EEG)
Stage 3 - 10-20% (deep/delta)
REM - 20-25% (dreams)
Non-REM/REM alternate every 90-100 - REM periods become increasingly longer as the night progresses
TCAs and seizures
- lower sz threshold
- levels may inc w/sz meds
metabolic monitoring for antipsychotics
fasting blood glc - baseline, 12wk, annual
BP - baseline, 12wk, annual
BMI - baseline, 4wk, 8wk, 12wk, quarterly
waist circum - baseline, annual
fasting lipid - baseline, 12wk, 5yr
ECT modalities
bilateral unilateral non dominant (right) - fewer cognitive SEs, less sx reduction (no absolute contraindications) 6-10 sessions 3x/wk 1 sz/session 25 second sz
can switch from uni to bilateral after 4-6 treatments if no improvements
Williams syndrome
ADHD elfin facies starburst facies IDD cheerful demeanor ease with strangers heart & blood vessel problems strabismus hypermuscularity hyperacusis (sensitivity to sounds)
autism spectrum disorder
1%
communication
social interaction
restriction of activities
childhood onset fluency disorder
5%
vagus nerve stimulation
FDA approvals
- epilepsy
- treatment resistant depression
placed in carotid sheath
thoracic/abdominal viscera - medulla
4 failed trials
ADHD
9%
2: 1 male:female (kids)
1. 6:1 male:female (adults)
adult cut off 5 sx (of 18)
kid cut off 6 sx
6mths
prior to age 12
ADHD + tics
clonidine
guanfacine
stimulant max doses (kids)
dexmethylphenidate (Focalin) 20mg
Methylin, Ritalin, Metadate 60mg
methylphenidate-OROS (Concerta) 72mg
methylphenidate patch (Daytrana) 30mg
meds to avoid w/ECT
theophylline - prolongs szs
hypoglycemincs (insulin/orals)
beta blockers - asystole
lidocaine - reduce sz induction
lithium - prolong sz and confusion/postictal delirium
clozapine (late appearing sx)
bupropion (late appearing sx)
benzos (anticonvulsant)
basilar migraine
transient headache occipital pain aura quadriplegia (stroke like) stupor psychosis blindness coma
serotonin syndrome
clonus
tachycardia
hyperthermia
leukocytosis rhabdomyolysis abnormal LFTs hypocalcemia hyponatremia hypomagnesemia
myoglobin - test for rhabdo
cocaine inhibits reuptake of serotonin
amphetamines dextromethorphan MDMA (ecstasy) St. Johns wort nefazodone meperidine (Demerol) fentanyl antiemetics carbamazepine antimigraine meds l-tryptophan
Korsakoff’s syndrome
thiamine deficiency
anterograde and retrograde amnesia
confabulation
apathy
herpes simplex encephalitis
temporal lobe
inferomedial frontal lobe
personality/behavior change
psychosis
gustatory & olfactory hallucinations
anosmia
xanthochromia PLEDS (periodic lateralized epileptiform discharges) on EEG
IV acyclovir
anterior pituitary
FSH LH ACTH TSH Prolactin Endorphins GH
brain cell types
neurons
glia
- astrocytes
- microglia (act like macrophages)
- macroglia
- -oligodendrocytes (insulate axons in CNS w/myelin sheath)
- -astrocytes (BBB, repair/scarring)
- -ependymal cells (line ventricles and help produce CSF)
- -radial glia (primary progenitors - neurons, astrocytes, oligos)
- -Schwann cells (myelinated nerves in PNS)
adrenoleukodystrophy
x-linked
accum. very long-chain fatty acids (VLCFA)
- myelin of CNS and adrenal cortex
mutations in ABCD1
vision & hearing impairment aphasia hyperactivity paralysis seizures muscle weakness adrenal failure coma
left parietal lobe
dominate
Gerstmanns syndrome
right-left confusion agraphia acalculia aphasia agnosia (inability to interpret sensations)
right parietal lobe
non dominate
dressing apraxia
difficulty understanding how things relate in space
left hemineglect
Brocas area
left frontal lobe
expressive aphasia
- understand what is being said
- difficulty forming spoken words
impaired naming and repetition
production of speech
Wernickes area
left temporal lobe
receptive aphasia
- unable to comprehend spoken language
- can still speak fluently (doesn’t make sense)
language development
comprehension of speech
Huntingtons disease
caudate and putamen
chromosome 4
CAG trinucleotide repeat
anticipation
huntington
- synaptic vesicle-associated protein
- accum. of intracellular toxic proteins
- degeneration of striatum
tx: tetrabenzazine
haldol - chorea
Creutzfeldt-Jakob disease
Real Time Quaking Index Conversion (RT-QuIC)
6-9mth mortality
CSF assay - tau proteins
periodic sharp wave complexes (PSWCs) on EEG
depression
anxiety
irritability
insomnia
temporal lobe
hearing
naming
visual recognition
facial recognition (fusiform gyrus)
parietal lobe
integrating sensory information
IQ
occipital lobe
primary visual cortex?
frontal lobe
executive functioning
social conduct
judgment
insight
tabes dorsalis
dorsal columns
untreated syphilis
sensory ataxia lightening pains urinary incontinence paresthesias diminished/absent reflexes hearing impairment
(neurosyphilis) dementia personality change confusion irritability depression visual disturbance Argyll Robertson pupils (accommodate but don't react to light)
endarterectomy
> 70% blockage
B12 deficiency
megaloblastic anemia (MCV >100) GI sx neurologic sx -dementia -numbness -depression -muscle weakness
pallor paresthesias decreased reflexes irritability poor concentration
posterior and lateral columns
can be caused by nitrous oxide abuse
cryptococcal meningitis
AIDS
encapsulated organism
India ink test
Amphotericin B
hippocampus
medial temporal lobe
alcohol-induced sleep disorder
early sedative effect
deep sleepiness for 3-4hrs
increased wakefulness
more restless sleep for several hrs
absence seizures
3-4Hz spikes and slow wave complexes
coma/encephalopathy
diffuse or anteriorly prominent theta and delta patterns
MAOIs
serotonin, NE, dopamine sexual side effects weight gain orthostatic hypotension edema insomnia
- ine (also TCAs)
- ide (also TCAs)
- id
- ane
- ole
- one
hydrazine Isocarboxazid nialamide phenelzine hydracarbazine tranylcypromine bifemelane moclobemide pirlindole toloxatone rasagiline selegiline (MAOI-B - dopamine only) safinamide
parasomnias
earlier phases of sleep
slow phase sleep
10-30% kids - sleep walk
50% kids w/sleepwalking or night terrors develop OSA
myasthenia gravis
antibodies bloc, destroy or inactive postsynaptic neuromuscular acetylcholine receptors
thymoma
worsens w/exertion
diplopia dysarthria dysphagia fatigue muscle weakness
edrophonium chloride - Tensilon test
(used to diagnose)
pyridostigmine plasmapheresis IVIG thymectomy steroids
Lambert-Eaton syndrome
impaired release of presynaptic acetylcholine
repetitive muscle exertion may temporarily correct sx
botulism
impaired release of presynaptic acetylcholine
botulism toxin blocks release of acetylcholine
REM sleep behavior disorder
15% Parkinsons
70% multiple system atrophy
85% Lewy body dementia
myotonic dystrophy
muscular dystrophy cataracts heart conduction defects endocrine changes myotonia hypersomnia frontal hair loss facial/temporal wasting problems w/executive functioning
involuntary contractions w/percussion of muscle
autosomal dominant trinucleotide repeat (CTG)
TCA overdose
<2 hrs - activated charcoal
>2hrs - IV sodium bicarbonate
(never induce emesis)
intubate
IV fluids
cardiovascular toxicity (widened QRS)
cortical blindness
Anton’s syndrome
deny blindness despite clinical evidence
bilateral occipital lobes
dementia
Alzheimers 60% vascular 15-30% Lewy body 4% frontotemporal 2% Parkinsons 2% all other causes 3%
Binswangers disease
dementia
2 of the following: hypertension/vascular disease cerebral vascular disease subcortical dysfunction -neurogenic bladder -muscular rigidity -gait abnormalities bilateral abnormalities of MRI/CT syncope pseudobulbar palsy
lead poisoning
hypochromic microcytic anemia (MCV <80) lead line in mucosa irritability seizures coma wrist-drop foot-drop peripheral neuropathies hypertension depression
limbic system
smell
emotion
hydrocephalus
dementia amnesia decreased psychomotor movement magnetic gait incontinence
Meige’s syndrome
tightly blinking eyes
grimacing
botox injections
thalamus
impaired visual memory (right)
language deficits (medial)
mood and sleep-wake-cycle (arterial and medial)
mammillary bodies
posterior diencephalon
lesions:
psychosis
memory deficits
confabulation
amygdala
behavioral issues emotional issues hypersexuality hyperorality hyperplasia
opioid intoxication
mitosis (constricted pupils) dec respiration dec bowel sounds nausea vomiting severe itching
naloxone
entacapone/tolcapone
catechol-O-methyltransferase (COMT) inhibitor
helps prevent degradation/metabolism of levodopa and dopamine
used in PD to reduce peripheral adverse effects of levodopa (has no actions by itself)
cluster headaches
young males episodic 15 mins - 3hrs nocturnal retroorbital ipsilateral autonomic sx
pts prefer moving their head or pacing
high flow oxygen
triptans (abortive)
corticosteroids (bridging)
verapamil (prophylaxis)
ethosuximide
absence seizures
can cause hyperactivity
reduces low threshold T-type calcium channels
valproic acid is 2nd choice
schizophrenia
1% 10% suicide risk 80% 5yr relapse w/o meds 40% 1yr relapse on meds women:men 1:1 chromosome 22
active phase 1mth
late onset after 45
sleep changes w/MDD
prolonged sleep latency inc wake time after sleep onset inc early morning awakenings dec total sleep time dec slow wave sleep dec slow wave sleep as % of total sleep time reduced REM latency prolongation of 1st REM sleep period inc REM activity inc REM sleep %
sleep changes w/GAD
longer sleep latency
inc freq of awakenings
normal REM latency
mesencephalon
(midbrain)
dopamine production
-substantia nigra
diencephalon
(interbrain) hypothalamus -control of hormone release -temperature regulation -sexual instincts -control of circadian rhythms (ventrolateral preoptic nucleus VLPO) -hydration
tuberomammillary nucleus
histamine
arousal promoting
itching
nucleus basalts of Meynert
acetylcholine
sweating
raphe nuclei
serotonin
nausea
locus coeruleus
norepinephrine
arterial vasoconstriction
ventral tegmental area
substantia nigra
-dopamine
pheochromocytoma
norepinephrine
sympathetic hyperactivity
urine vanillyl mandelic acid (VMA)
urine metanephrines
adrenal mass
anti-NMDA receptor encephalitis
young women
follows flu-like illness
ovarian teratomas
paraneoplastic syndrome
psychosis anterograde amnesia hallucinations suicidal ideation dyskinesias autonomic instability
drug induced Parkinsonism
remove offending agent
alpha-synucleinopathy
Parkinsons
multiple system atrophy
Lewy body dementia
tauopathy
Alzheimers
Picks disease
cholinesterase inhibitors
reversible
donepezil
rivastigmine
galantamine
tacrine
start early
continue indefinitely
may reduce rate of cognitive decline
GI side effects
- nausea
- vomiting
- diarrhea
- abdominal cramping
- improve w/time
medial longitudinal fasciulus
conjugate eye movement
HARP syndrome
Hypobetalipoproteinemia (low cholesterol)
Acanthocytosis (speculated red blood cells)
Retinitis pigmentosa (pigment deposits on retina - loss of vision)
Pallidal degeneration
atonic seizures
slow spikes and waves
or polyspikes and waves
hyper somnolence disorder
sleepiness despite 7 hrs in main sleep period
at least 3x/wk for 3mths
NMDA-receptor antagonist
moderate-severe dementia
memantine
delirium
12-40% geriatric pts
10-15% all pts
37% post op pts
22-33% 3mth mortality rate
generalized slow wave and theta/delta waves on EEG
sleep
adolescence - stage 3 and 4 peak
newborns - 50% REM
number of awakenings and amount of”light” stage 1 sleep inc in later adulthood
narcolepsy
3x/wk for 3mths
cataplexy
and/or
intrusion of REM sleep into transition between wake/sleep
hypnopompic and hypnagogic hallucinations
low levels CSF hypocretin (orexin)
sodium oxybate (Xyrem)
methylphenidate (Ritalin)
modafanil (Provigil)
structured napping times during the day
carbidopa/levodopa
levodopa - converted to dopamine in CNS and peripherally
carbidopa - reduces peripheral conversion into dopamine (reducing side effects)
-inhibits DOPA decarboxylase
pons
arousal
sleep-wake cycles
memory
language
brain mets
most common - non-small cell lung cancer
greatest risk to metastasize - melanoma and small cell lung cancer
breast (? 2nd)
renal
GI cancers
amaurosis fugax
brief loss of vision
black curtain coming down
internal carotid artery
paroxysmal hemicrania
several headaches in 1 day
short (2-30mins)
lacrimation
conjunctival inaction
neck movements trigger episodes
women
responsive to indomethacin
anticipation
more trinucleotide repeats = earlier age of onset of sx
Huntingtons (CAG)
Friedrich ataxia
myotonic dystrophy
Sydenham’s chorea
group A strep
kids
girls
OCD traits
irritability
restlessness
20-30% pts rheumatic fever
lower sx threshold
SSRIs = safe
```
bupropion
venlafaxine
TCAs?
amoxapine
clomipramine
maprotiline
~~~
trigeminal neuralgia
radiating jaw pain
electric, shock like pain
worsened by cold
worsened by trivial stimuli (touching)
carbamazepine
phenytoin
gabapentin
(no NSAIDs)
Erickson’s stages
0-2 yrs trust vs mistrust 2-4 yrs autonomy vs shame/doubt (toilet training) 4-5 yrs initiative vs guilt (starting school) 5-12 yrs industry vs inferiority 13-19 yrs identity vs role confusion 20-39 yrs intimacy vs isolation 40-64 yrs generatively vs stagnation 65-death ego integrity vs despair
Piaget’s stages
cognitive development
birth-2 yrs sensorimotor
-object permanence
2-6 yrs pre-operational
- egocentrism
- rules are fixed
- ability to use symbols and language
7-11 yrs concrete operational
- conservation of liquids
- logic and objectivity
- reversibility
- transitivity
- classification
11yrs-adult formal operations
- abstract
- hypothetical
- major principles
- motivations
kleptomania
naltrexoine
fluoxetine
SSRIs
no meds FDA approved
operant conditioning
positive reinforcement
-add desirable stimulus to increase desired behavior
positive punishment
-add undesirable stimulus to decrease undesired behavior
negative reinforcement
-remove undesirable stimulus to increase desired behavior
negative punishment
-remove desirable stimulus to decrease undesired behavior
play types
2 yrs - parallel play
3 yrs - associative play
4 yrs - cooperative play
Freud’s stages
birth-18 mths oral 18 mths-3 yrs anal 3-5 yrs phallic 5-12 yrs latency 12-15 yrs genital
Tourettes
haldol pimozide Abilify botox clonidine
Seroquel worsens tics
Wernicke encephalopathy
acute phase of Korsakoffs syndrome
medical emergency
thiamine deficiency
confusion
ophthalmoplegia
ataxia
nystagmus
delirium
amnesia
microhemorrhages in periventricular grey matter around ventricles
give thiamine BEFORE glucose to avoid worsening of sxs
Mahler’s stages
autistic phase (first weeks)
- total detachment
- self-absorption
symbiotic phase (until 5mths)
- recognizes mother
- lacks sense of individuality
seperation-individuation
- hatching (differentiation?)
- shows increased interest in outside world
- practicing (9-16mths)
- develops ability to separate from mother
- rapprochement (15-24mths)
- explores outside world, but requires mother is present and able to support appropriately and emotionally in completing the task
object constancy (2-5yrs)
Kohlbergs developmental theories
3 levels of moral reasoning
preconventional
conventional
postconventional
ADHD scales
Connors Index Scale
SNAP-IV Rating Scale-Revised
Vanderbilt Diagnostic Rating Scale
identification
pts w/conversion disorder exhibit sxs similar to someone important to them
conversion disorder
subconscious
1-3% of pts w/neuro sis
neurologic sxs not solely limited to pain
young females low SES rural areas not well-educated lack of concern about sxs
factitious disorder
pt feigns sxs in order to seek the sick role
malingering
pt feigns sxs for secondary gain
personality disorders
cognition
affectivity
interpersonal functioning
impulse control
15% population
antisocial - males (1% females) borderline - females histrionic - females dependent - female/neutral avoidant - female/neutral schizoid - male/neutral
schizoid
pervasive pattern of detachment from social relationships
restricted range of emotions
schizotypal
3% population
pervasive pattern of social and interpersonal discomfort with and reduced capacity for close relationships
cognitive or perceptual distortions and eccentricities
relatives w/schizophrenia
constraint
how easily an individual acts on an initial, emotionally based evaluation of events and people
foundation of conscientiousness
self-system
stable and realistic sense of self
social system
means of interpreting social situations and understanding the relational motives and actions of others
self-in-relation system
capacity to observe the self as it relates to others
narcissistic personality disorder
caused by inadequate soothing in Mahler’s symbiotic phase (up to 5mths) and inadequate refueling during separation-individuation (6-24mths)
psychoanalysis (Kohut, Kernberg)
group therapy
borderline personality disorder
2-3% population
12-15% clinical settings
caused by disruption of Mahler’s rapprochement (15-24mths)
acting out
splitting
SSRIs
antipsychotic
mood stabilizer
DBT
mentalization based therapy
sublimation
take negative stimulus and associated appropriate emotional response and instead convert negative response into a positive and often productive response
interpersonal therapy
12-16 weeks
relaxed/supportive
beginning - 1-3 sessions (identify target diagnosis and interpersonal context in which it presents)
middle (specific strategies)
end - 1-3 sessions
focuses on improving relationships in the present (not on what causes sxs)
negative interpersonal experiences lead to depression
induction of sick role
explaining cause of pt’s interpersonal problems (beginning phase)
complicated bereavement
-grief after loss of loved one
role dispute
-conflict in significant relationships
role transition
-difficulties adapting to change in relationships or life circumstances
interpersonal deficits
-difficulties stemming from social isolation or lack of life events (absence of one of the other 3)
psychodynamic therapy
focuses on unconscious motivations
aversive conditioning
using punishment to decrease target behavior
habituation
learning response that decreases over time as same stimulus is repeated
extinction
decrease in conditioned response due to lack of reinforcement
continuous reinforcement
reward is given every time the target response occurs
law of effect
responses that produce a satisfying effect in a particular situation are more likely to occur again in that situation
response that produce a discomforting effect are less likely to occur
negative practice
reducing a behavior by repeating the response intensely
modeling/observational learning
behavior that is learned by watching others
paranoid personality disorder
individual psychotherapy
not overly warm
10-30% psych inpatients
tertiary prevention
prevent deterioration or reduce complications of disease
ACT
metabolic monitoring
intensive case management
secondary prevention
detects diseases early when pts are asymptomatic
HIV testing
screening
prodromal schizophrenia
primary prevention
keeps disease from occurring by removing its causes
lifestyle changes
immunizations
suicide prevention programs
privilege
possessed by the individual patient, not the patient
hydrazine
MAOI
Isocarboxazid
MAOI
nialamide
MAOI
phenelzine
MAOI
hydracarbazine
MAOI
tranylcypromine
MAOI
aphasia vs dysarthria
aphasia - disturbance of language (cognitive function)
dysarthria - disturbance of speech (motor function)
scanning
slurred speech with variable cadence and volume
cerebellum
dysdiadochokinesia
impaired ability to perform rapid, alternating movements
cerebellar damage
T10
sensation below umbilicus
spastic leg weakness
Foster-Kennedy syndrome
depression
frontal lobe tumor
optic nerve compression
optic atrophy
papilledema
chromosome 1
alzheimers disease
presenillin 2
chromosome 3
von Hippel-Lindau syndrome
chromosome 4
Huntington disease
Parkinson disease alpha-synuclein gene
chromosome 5
infantile and juvenile spinal muscular atrophy
Werdnig-Hoffma and Kugelberg-Welander diseases
chromosome 6
Creutzfeldt-Jakob disease
Parkinson disease, Parkin
spinocerebellar ataxia type 1
chromosome 7
Williams syndrome
chromosome 9
dystonia (early-onset primary dystonia - DYT1)
Fredreich ataxia
tuberous sclerosis complex 2
chromosome 12
phenylketonuria
chromosome 13
Wilson disease
chromosome 15
Angelman syndrome
dyslexia
Prader-Willi syndrome
Tay-Sachs (hexosaminidase A deficiency)
chromosome 16
tuberous sclerosis complex 2
chromosome 17
Charcot-Marie-Tooth disease
frototemporal lobar degeneration
Narcolepsy-cataplexy
neurofibromatosis type I
chromosome 19
apolipoprotein E
familial hemiplegic migraine
malignant hyperthermia susceptibility
myotonic dystrophy
chromosome 20
fatal familial insomnia
chromosome 21
homocystinuria
myoclonic epilepsy
trisomy 21
chromosome 22
metchromatic leukodystrophy neurofibromatosis type 2 velocardiofacial DiGeorge syndrome schizophrenia
x chromosome
adrenoleukodystrophy Duchenne muscular dystrophy Fragile X syndrome Lesch-Nyhan syndrome Rett syndrome
CGG
Fragile X syndrome
x linked
sex linked
GAA
Friedreich ataxia
chromosome 9
autosomal recessive
CAG
Huntingtons disease
- chromosome 4
- autosomal dominant
spinocerebellar atrophies
- autosomal dominant
- type 1 (chromosome 6)
- type 2 (chromosome 12)
- type 3 (chromosome 14)
CTG
myotonic dystrophy
chromosome 19
autosomal dominant
GCC
oculopharyngeal dystrophy
chromosome 14
autosomal dominant
atropine/scopolamine
blocks cerebral acetylcholine receptors
delirium
amnesia
anticholinergic effects
organophosphate insecticides/nerve gas
inhibit cholinesterase (irreversible)
- increases acetylcholine
- cholinergic toxicity
postsynaptic dysfunction
brief stimulation, then paresis of all muscles
increased parasympathetic activity
confusion
seizures
Diarrhea Urination Miosis Bradycardia Emesis Lacrimation Salivation/sweating/secretion
tx: atropine + pralidoxime
upper motor neuron signs
weakness hyperreflexia tight muscles clonus Babinski sign
lower motor neuron signs
weakness areflexia paralysis atonia fasciculations
posterior columns
position and vibration
fasciculus cuneatus
fasciculus gracilis
lateral spinothalamic tract
pain and temperature
T4
nipples
anosognosia
lack of self-awareness of deficit
neuropathy vs myelopathy
neuropathy - damage to nerves outside the CNS
myelopathy - damage to the spinal cord
Wisconsin card sorting test
executive functioning
color, form, number
Boston naming test
anomia (unable to recall names of everyday objects)
operant conditioning scheduling
fixed-interval
-reinforcement for response that occurs after set time
fixed-time
-reinforcement after fixed time, regardless whether behavior performed
fixed-ratio
-reinforcement every set number of responses
variable interval
- reinforcement for responses after varying amounts of time
- response varies w/time (checking email throughout the day to monitor for important messages)
variable ratio
-reinforcement at a varying response rate
(slot machines)
negative contrast
switched from high reward to low reward
paradoxically weakens behavior more than simply receiving low reward all along
reinforce devaluation
subject denies previously positive reinforcer is no longer valued and cannot be used to strengthen behavior any longer
varenicline (Chantix)
partial agonist at alpha4beta2
full agonist at alpha 7
binds to receptors avidly, but stimulates receptors more weakly than nicotine, reducing cravings but also limiting the pleasurable effects of smoking
hypericum perforatum
St. Johns Wart
antidepressant
anxiolytic
no (serotonin syndrome)
- SSRIs
- MAOIs
ginkgo biloba
improves memory
impairs anti platelet memory (causes bruising)
echinacea purpurea
improves immune system
lithium
cerebellar damage
diabetes insipidus
- polyuria (single bedtime dose)
- polydipsia (single bedtime dose)
- hypernatremia
- treat w/amiloride (K sparing diuretic)
hyperparathyroidism
- decrease lithium clearance
- increase lithium levels
- -lisinopril
- -NSAIDs
- -HCTZ
- -low sodium diet
- decrease lithium level
- -high sodium diet
level not affected by aspirin
insulin-like effect
reduces affect of ADH on kidney
CYP 3A4 inducers
carbamazepine oxcarbazepine phenobarbital/barbiturates phenytoin oxcarbazepine ethosuxamide steroids progesterone St. John's wort rifampin (lots of r's)
CYP 3A4 inhibitors
(lots more) valproic acid nefazodone fluoxetine sertraline fluvoxamine amiodarone cannabinoids diltiazem entacapone erythromycin grapefruit juice omeprazole ranitidine ketoconazole
CYP 2D6 inhibitors
fluoxetine
sertraline
paroxetine
duloxetine
spinal cord
ends at T12-L1
Brown-Sequard syndrome
hemitransection of thoracic spine
(loss of pain sensation contralateral to paresis)
injury to lateral corticospinal tract= ipsilateral -leg paresis -hyperactive DTRs -Babinski sign
injury to posterior columns=
ipsilateral
-impairment in vibration and position sense (proprioception)
injury to spinothalamic tract=
contralateral
-loss of temperature and pain sensation
cranial nerves
I Olfactory II Optic III Oculomotor IV Trochlear V Trigeminal VI Abducens VII Facial VIII Vestibulocochlear (Acoustic) IX Glossopharyngeal X Vagus XI Spinal XII Hypoglossal
spinocerebellar ataxia
posterior column abnormalities (sensory loss) Babinski sign limb ataxia scanning speech pes cavus
trineucleotide repeat
chromosome 6
autosomal recessive
NRTs
(fastest to slowest)
tobacco cigarette spray (10-15mins) inhaler lozenge (20-30mins) gum (30-60mins) patch (2-9hrs)
short acting - 3mths
buspirone
5-HT1A partial agonist at postsynaptic receptors
5-HT1A full agonist at presynaptic receptors
mild-moderate presynaptic D2, D3, D4 antagonist
partial alpha1 agonist
mirtazapine
tetracyclic antidepressant
- alpha-2 adrenergic antagonist
- increases release of. norepinephrine
- histaminic antagonism
- -sedation
- -inc appetite
- -weight gain
- 5-HT3 antagonist (anti-nausea)
- (also 5-HT2 antagonist)
atomoxetine
norepinephrine reuptake inhibitor
carbamazepine
SIADH hyponatremia elevated LFTs hepatitis decreased WBCs agranulocytosis pancytopenia aplastic anemia Stevens-Johnson
check LFTs
blockage of type 2 sodium channels
lamotrigine
cleft lip
cleft palate
lower dose w/valproate
valproate
neural tube defect
20-30mg/kg loading dose
increased by:
- cimetidine
- macrolide abx (erythromycin)
- felbamate
decreased by:
- carbamazepine
- phenytoin
- primidone
- phenobarbital
pancreatitis increased amylase tremor alopecia ankle swelling thrombocytopenia hepatic failure (BLACK BOX)
glutamate
excitatory
precursor to GABA
learning
memory
receptors
- AMPA
- NMDA
- kainate
acute intermittent porphyria
confusion hallucinations flaccid paresis abdominal pain red urine
Watson-Schwartz test
contraindicated (can precipitate/worsen attack)
- barbiturates
- phenytoin
bupropion
dopamine-norepinephrine reuptake inhibitor
tardive dyskinesia
all typicals
5%/yr
10-20% treated for more than a year
20-40% hospitalized long term
women
children
elderly
brain damage
less
- seroquel
- clozaril
- geodon
buprenorphine-naloxone
buprenorphine
- partial agonist at mu-opiod receptor
- antagonist at kappa-opioid receptor
naloxone
-antagonist at mu-opiod receptor
hypnotic half life
shortest to longest
zaleplon (Sonata) ramelteon (Rozerem) zolpidem (Ambien) / triazolam (Halcion) eszopiclone (Lunesta) temazepam (Restoril)
CYP450 inhibitor
valproate
fluoxetine
fluvoxamine
sertraline
CYP450 inducer
phenytoin
carbamazepine
phenobarbital
rifampin
clozapine
neutropenia
myocarditis
eosinophilic colitis
fluvoxamine - inc clozapine levels
dopamine, serotonin, alpha antagonist
Xyrem (sodium oxybate)
narcolepsy
GABA-B
false positives
venlafaxine - PCP amitriptyline - LSD naproxen - barbiturates sertraline - benzos trazodone - amphetamine
panic disorder
1mth
sertraline
fluoxetine
paroxetine
CBT
oral contraceptives
carbamazepine - dec OCPs
oxcarbazepine - dec OCPs
topiramate >200mg
seizure threshold
bupropion clozapine theophylline clomipramine clozapine
alcohol
cocaine
stimulants
SSRIs
inc risk of bleeding - reduction of serotonin in plts
GI SEs most common in sertraline and fluvoxamine (5HT-3)
CNS activation (anxiety, restlessness, tremor, insomnia) most common in fluoxetine
sedation most common in paroxetine
SIADH most common in fluoxetine
akathisia/EPS rare - most common in sertraline
GAD
venlafaxine
paroxetine
escitalopram
duloxetine
ginseng
can interact with
- phenelzine
- lithium
- neuroleptics
can cause
- irritability
- insomnia
- mania
pyroxidine
vit B6
deficiency
- MAOIs
- isoniazid (INH)
nefazodone
black box warning
- liver failure
- suicidality
hypotension
bradycardia
kava kava
sedative
anesthetic
consumed as a beverage
should not be used w/benzos, alcohol or barbiturates
liver toxicity
cyp 2D6 inducer
dexamethasone
rifampicin
couples therapy
behavioral exchange
communication training
problem solving
interpersonal therapy
communication analysis - (identify maladaptive communication patterns to help pt communicate effectively)
construct a timeline - understand relationship between depression and interpersonal experiences
treats depression
focuses on current relationships
4 core issues
- grief
- role transition
- role dispute
- interpersonal deficits
depressive disorder therapy
IPT
CBT
psychodynamic therapy
working through - identify patterns of defense mechanisms and object relations - make the subconscious conscious
cognitive behavioral therapy
most widely used depression anxiety schizophrenia not personality disorders
identification of dysfunctional cognitions
role playing
thought mood logs
automatic thoughts
exposure and response therapy
dialectical behavioral therapy
assumes pts are doing the best they can, and they need to do even better
chain analysis
patient capabilities
group skills training
individual therapy
phone consultations
consultation team
Lazarus coping - model for stress management
self exploration
self instruction
self correction
self rehearsal
anorexia
hypokalemia elevated BUN hypercholesteremia hyperamylasemia hypomagnesemia hypophosphatemia
cardiac arrhythmias
osteoporosis
lanugo
female
adolescent
perfectionistic
prochlorperazine
phenothiazine
typical antipsychotic
nausea
vomiting
vertigo
eszopiclone
Lunesta
short acting
daytime sleepiness
fatigue
taste disturbance
Jean Baker Miller
relational theory
Sigmund Freud
structural theory
Anna Freud
ego psychology
defense mechanisms
Carl Jung
transpersonal psychology
analytic psychology
growth of personality
Melanie Klein
object relations theory
bad mother
tension between true and false self
paranoid-schizoid position - parts of mother as all good or all bad
depressive position - mother ambivalent, having both positive and negative aspects
Kohut v Kernberg
Kohut (self psychology)
- self-object
- supportive
- transference
- -mirroring (affirming/positive responses used to see positive responses in self)
- -idealization (calm and soothing other provides comfort when unable to do so for self)
Kernberg
- confronting
- defenses
- -splitting
- -projectice identification
- -primitive idealization
supportive therapy
reduce symptoms
improve self-esteem and functioning
therapist makes suggestions and gives advice
Kurt Schneider
first rank symptoms
Eugene Bleuler
coined the term schizophrenia
the 4 As loose Associations Affective flattening Autism Ambivilance
Emil Kraeplin
used the term dementia praecox (created by Morel)
classified schizophrenia as a physical disease
differentiated schizophrenia from manic-depressive illness
assertiveness training
behavioral therapy
avoidant personality disorder
neurosis
unconscious conflict between opposing wishes or between wishes and prohibitions
abreaction
process that occurs when repressed memory and associated affect is brought into consciousness
Josef Breuer
contemporary and friend of Freud
helped develop theory of hysteria
Salvador Minuchin
structural family therapy
medial frontal lobe lesion
apathy
limited spontaneous movement, gesture, speech
left frontal lobe lesion
depression
Broca’s area?
right frontal lobe lesion
mania
ailurophobia
dread of cats
cohort study
follow population over period of time
longitudinal study
case-control study
retrospective
examines persons without a particular disease
clinical trial
some patients get treatment
another group does not
assigned randomly
goal to determine effectiveness of treatment
cross-sectional survey
describe prevalence in a population at a particular point in time